Chlorhexidine Shortage: A Provider Briefing for 2026

Chlorhexidine Gluconate (CHG) remains a cornerstone of infection prevention across dentistry, surgery, and critical care. However, supply disruptions affecting certain CHG formulations have created challenges for providers and their patients. This guide summarizes the current landscape and offers practical strategies for managing availability constraints in your practice.

Shortage Timeline and Background

Chlorhexidine products have appeared intermittently on the ASHP drug shortage list since 2020. The timeline of key events includes:

• 2020-2021: Initial supply disruptions linked to increased demand during the COVID-19 pandemic, particularly for CHG-based hand hygiene and skin antisepsis products.
• 2022-2023: Manufacturing capacity issues at key production facilities led to persistent shortages of CHG bathing cloths and surgical prep applicators. Raw material sourcing challenges compounded the problem.
• 2024: Some improvement in oral rinse availability as additional generic manufacturers entered the market. Hospital-grade products (2% CHG/70% IPA applicators, CHG-impregnated cloths) continued to experience limited supply.
• 2025-2026: The oral rinse market has largely stabilized. Specialty hospital products remain intermittently affected. The overall drug shortage landscape remains elevated, with ASHP tracking over 200 active shortages.

Prescribing Implications

The shortage's impact varies by clinical setting and formulation:

Dental and Periodontal Practice

The 0.12% CHG oral rinse (Peridex, Periogard, generics) is the primary formulation affected by retail-level shortages. While multiple generic manufacturers exist, individual pharmacies may experience stockouts. Considerations for prescribers:

• Patients may need to check multiple pharmacies or use tools like Medfinder for providers to locate stock.
• Consider writing prescriptions as "Chlorhexidine Gluconate 0.12% oral rinse" (generic) rather than specifying a brand to maximize fill rates.
• For mild gingivitis, CPC-containing OTC mouthwashes may serve as a reasonable interim alternative.
• For moderate to severe disease, the clinical benefit of CHG may warrant the extra effort to source it.

Surgical and Hospital Settings

The most significant shortages have affected hospital-grade products:

• CHG bathing cloths: Used in ICU decolonization protocols, these have experienced the most persistent shortages. Facilities may need to switch to liquid CHG solutions applied with standard washcloths.
• Surgical prep applicators (2% CHG/70% IPA): Products like ChloraPrep have had limited availability. Povidone-Iodine-based preps or alternative CHG formulations may be necessary.
• Surgical hand scrubs: 4% CHG scrub solutions are generally available from generic manufacturers.

Current Availability Picture

As of early 2026, the availability landscape for Chlorhexidine is:

• 0.12% oral rinse: Generally available. Sporadic stockouts at individual pharmacies. Multiple generic options exist.
• 4% topical cleanser (OTC): Widely available. Hibiclens and generics stocked at major retailers.
• 2% CHG/70% IPA surgical preps: Intermittent availability. Some improvement over 2023-2024, but not fully resolved.
• CHG bathing cloths: Most constrained category. Facilities should maintain alternative protocols.

Cost and Access Considerations

Chlorhexidine remains one of the most affordable antimicrobial products in clinical use:

• Generic 0.12% oral rinse: Retail $21-$39; as low as $5-$10 with discount coupons (GoodRx, SingleCare).
• OTC 4% cleanser: $8-$15 retail.
• Insurance coverage: The oral rinse is generally covered by dental and medical plans with low copays. Prior authorization is typically not required.

For patients experiencing financial barriers, pharmacy discount coupons offer the most significant savings. No manufacturer-specific patient assistance programs exist for generic Chlorhexidine, but general assistance resources like NeedyMeds and RxAssist may help patients with other financial needs.

Tools and Resources for Providers

Several resources can help you and your patients navigate Chlorhexidine availability:

• Medfinder for Providers: Real-time pharmacy stock checking tool. Help patients identify which local pharmacies have Chlorhexidine available before sending them on a search.
• ASHP Drug Shortages Resource Center: Monitor current shortage status and access clinical management strategies at ashp.org/drug-shortages.
• FDA Drug Shortage Database: Official FDA tracking of shortage status and expected resolution timelines.
• Pharmacy discount coupons: Direct patients to GoodRx or SingleCare to reduce out-of-pocket costs. The generic oral rinse can be as low as $5 with a coupon.

Alternative Antiseptic Agents

When Chlorhexidine is unavailable, evidence-based alternatives include:

• Povidone-Iodine (Betadine): Broad-spectrum antiseptic effective for skin prep. Meta-analyses suggest slightly lower efficacy than CHG for surgical site infection prevention, but it remains a well-established option.
• Cetylpyridinium Chloride (CPC): OTC antiseptic mouthwashes suitable for mild gingivitis management.
• Essential oil mouthwashes (Listerine): FDA-accepted for plaque and gingivitis reduction. Alcohol content may be a concern for some patients.
• Octenidine: Used more widely in Europe as a CHG alternative for wound care and skin antisepsis. Limited availability in the US market.

For a patient-facing overview of alternatives, direct patients to our guide on alternatives to Chlorhexidine.

Looking Ahead

The Chlorhexidine supply situation is expected to continue improving in 2026, particularly for the oral rinse and OTC formulations. The hospital-grade specialty products may take longer to fully normalize as manufacturing capacity catches up with institutional demand.

Providers should maintain awareness of current shortage status, keep alternative protocols ready, and leverage tools like Medfinder to help patients navigate availability challenges efficiently. Proactive communication with patients about potential supply issues — and having a backup plan in place — can prevent delays in care.

Final Thoughts

While Chlorhexidine shortages are less acute than those affecting many other medications, they remain a practical challenge for dental and surgical practices. By staying informed, maintaining alternative protocols, and using available tools, providers can minimize the impact on patient care.

For a practical guide on helping patients locate Chlorhexidine, see our provider's guide to finding Chlorhexidine in stock. For saving strategies you can share with patients, see our provider's guide to helping patients save on Chlorhexidine.